vs
InfuSystem Holdings, Inc（INFU）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
InfuSystem Holdings, Inc的季度营收约是REDWOOD TRUST INC的1.4倍（$36.2M vs $25.9M），InfuSystem Holdings, Inc同比增速更快（7.0% vs -6.1%），过去两年InfuSystem Holdings, Inc的营收复合增速更高（6.4% vs -41.0%）
InfuSystem Holdings, Inc.是总部位于美国的医疗服务及设备供应商，主打输液治疗解决方案，提供可编程输液泵、配套一次性医用耗材及专业临床支持服务，服务覆盖北美地区的肿瘤诊所、家庭医疗服务商及急症护理机构。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
INFU vs RWT — 直观对比
营收规模更大
INFU
是对方的1.4倍
$25.9M
营收增速更快
INFU
高出13.1%
-6.1%
两年增速更快
INFU
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.2M | $25.9M |
| 净利润 | — | $20.0M |
| 毛利率 | 56.4% | — |
| 营业利润率 | 10.3% | — |
| 净利率 | — | 77.2% |
| 营收同比 | 7.0% | -6.1% |
| 净利润同比 | — | 402.6% |
| 每股收益（稀释后） | $0.09 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INFURWT
| Q4 25 | $36.2M | $25.9M | ||
| Q3 25 | $36.5M | $15.0M | ||
| Q2 25 | $36.0M | $13.8M | ||
| Q1 25 | $34.7M | $27.9M | ||
| Q4 24 | $33.8M | $27.6M | ||
| Q3 24 | $35.3M | $25.5M | ||
| Q2 24 | $33.7M | $67.4M | ||
| Q1 24 | $32.0M | $74.5M |
净利润INFURWT
| Q4 25 | — | $20.0M | ||
| Q3 25 | $2.3M | $-7.7M | ||
| Q2 25 | $2.6M | $-98.5M | ||
| Q1 25 | $-267.0K | $16.1M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $1.8M | $14.8M | ||
| Q2 24 | $717.0K | $15.5M | ||
| Q1 24 | $-1.1M | $30.3M |
毛利率INFURWT
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — | ||
| Q1 24 | 51.5% | — |
营业利润率INFURWT
| Q4 25 | 10.3% | — | ||
| Q3 25 | 10.4% | -9.0% | ||
| Q2 25 | 10.5% | -679.0% | ||
| Q1 25 | 1.8% | 80.2% | ||
| Q4 24 | 7.7% | -1.3% | ||
| Q3 24 | 9.2% | 86.1% | ||
| Q2 24 | 5.5% | 30.3% | ||
| Q1 24 | -2.6% | 41.3% |
净利率INFURWT
| Q4 25 | — | 77.2% | ||
| Q3 25 | 6.2% | -51.4% | ||
| Q2 25 | 7.2% | -712.0% | ||
| Q1 25 | -0.8% | 57.8% | ||
| Q4 24 | — | -24.0% | ||
| Q3 24 | 5.1% | 58.1% | ||
| Q2 24 | 2.1% | 23.0% | ||
| Q1 24 | -3.5% | 40.6% |
每股收益（稀释后）INFURWT
| Q4 25 | $0.09 | $0.11 | ||
| Q3 25 | $0.11 | $-0.08 | ||
| Q2 25 | $0.12 | $-0.76 | ||
| Q1 25 | $-0.01 | $0.10 | ||
| Q4 24 | $0.05 | $-0.08 | ||
| Q3 24 | $0.08 | $0.09 | ||
| Q2 24 | $0.03 | $0.10 | ||
| Q1 24 | $-0.05 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $255.7M |
| 总债务越低越好 | $19.6M | — |
| 股东权益账面价值 | $57.3M | $982.6M |
| 总资产 | $100.6M | $23.7B |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资INFURWT
| Q4 25 | $3.2M | $255.7M | ||
| Q3 25 | $955.0K | $226.3M | ||
| Q2 25 | $720.0K | $302.0M | ||
| Q1 25 | $1.5M | $259.9M | ||
| Q4 24 | $527.0K | $245.2M | ||
| Q3 24 | $380.0K | $253.7M | ||
| Q2 24 | $146.0K | $275.6M | ||
| Q1 24 | $822.0K | $275.4M |
总债务INFURWT
| Q4 25 | $19.6M | — | ||
| Q3 25 | $20.9M | — | ||
| Q2 25 | $26.3M | — | ||
| Q1 25 | $28.7M | — | ||
| Q4 24 | $23.9M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $34.2M | — | ||
| Q1 24 | $29.9M | $1.7B |
股东权益INFURWT
| Q4 25 | $57.3M | $982.6M | ||
| Q3 25 | $55.5M | $999.0M | ||
| Q2 25 | $54.5M | $1.1B | ||
| Q1 25 | $55.1M | $1.2B | ||
| Q4 24 | $57.5M | $1.2B | ||
| Q3 24 | $55.5M | $1.2B | ||
| Q2 24 | $53.5M | $1.2B | ||
| Q1 24 | $52.3M | $1.2B |
总资产INFURWT
| Q4 25 | $100.6M | $23.7B | ||
| Q3 25 | $98.9M | $22.6B | ||
| Q2 25 | $100.8M | $21.3B | ||
| Q1 25 | $104.3M | $19.9B | ||
| Q4 24 | $103.6M | $18.3B | ||
| Q3 24 | $105.3M | $18.4B | ||
| Q2 24 | $108.5M | $16.5B | ||
| Q1 24 | $104.8M | $15.1B |
负债/权益比INFURWT
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 0.64× | — | ||
| Q1 24 | 0.57× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.1M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $7.0M | — |
| 自由现金流率自由现金流/营收 | 19.3% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $23.8M | — |
8季度趋势，按日历期对齐
经营现金流INFURWT
| Q4 25 | $7.1M | $-10.1B | ||
| Q3 25 | $8.5M | $-2.7B | ||
| Q2 25 | $7.0M | $-2.1B | ||
| Q1 25 | $1.8M | $-2.0B | ||
| Q4 24 | $7.9M | $-5.9B | ||
| Q3 24 | $9.8M | $-2.1B | ||
| Q2 24 | $2.3M | $-2.0B | ||
| Q1 24 | $377.0K | $-954.2M |
自由现金流INFURWT
| Q4 25 | $7.0M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $195.0K | — |
自由现金流率INFURWT
| Q4 25 | 19.3% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 21.9% | — | ||
| Q3 24 | 27.7% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 0.6% | — |
资本支出强度INFURWT
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.6% | — |
现金转化率INFURWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 2.70× | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.45× | -140.86× | ||
| Q2 24 | 3.22× | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
RWT
暂无分部数据
